Cargando…
A Novel off-the-Shelf Trastuzumab-Armed NK Cell Therapy (ACE1702) Using Antibody-Cell-Conjugation Technology
SIMPLE SUMMARY: Chimeric antigen receptor T cell therapy has shown its potency against hematologic malignancies in autologous settings but also limited success against solid tumors with severe adverse events, including fatal cases of cytokine releasing syndrome. The aim of this research is to develo...
Autores principales: | Li, Hao-Kang, Hsiao, Ching-Wen, Yang, Sen-Han, Yang, Hsiu-Ping, Wu, Tai-Sheng, Lee, Chia-Yun, Lin, Yan-Liang, Pan, Janet, Cheng, Zih-Fei, Lai, Yan-Da, Hsiao, Shih-Chia, Tang, Sai-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199224/ https://www.ncbi.nlm.nih.gov/pubmed/34072864 http://dx.doi.org/10.3390/cancers13112724 |
Ejemplares similares
-
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Heipertz, Erica L., et al.
Publicado: (2021) -
A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy
por: Cheng, Zih-Fei, et al.
Publicado: (2021) -
A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma
por: Li, Hao-Kang, et al.
Publicado: (2023) -
Current Perspectives on the Use of off the Shelf CAR-T/NK Cells for the Treatment of Cancer
por: Cutmore, Lauren C., et al.
Publicado: (2021) -
1702 A Comparative Analysis of Tuberculous and Brucellar Spondylodiscitis
por: Koubaa, Makram, et al.
Publicado: (2014)